Healthcare -
Biotechnology - NASDAQ - US
$ 47.57
1.27 %
$ 2.33 B
Market Cap
-25.71
P/E
MIRM - COST OF REVENUE
Cost of Revenue MIRM - Mirum Pharmaceuticals, Inc.
47 M
LAST VALUE
397.18%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR